Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing type
4
Filing date
Jan 13, 2026
Updated
Jan 14, 2026 ยท 2:23 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership